Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
US12384854B2 · kind B2 · utility
0Cited by
19References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2020 |
| Grant date | Aug 12, 2025 |
| Priority date | — |
| Expiry date | Mar 10, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.